Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with oral acyclovir.
Balfour
H H
HH
Department of Laboratory Medicine, University of Minnesota Health Sciences Center, Minneapolis 55455.
Fletcher
C V
CV
Dunn
D
D
D000212:Acyclovir / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000284:Administration, Oral; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006801:Humans; D007167:Immunotherapy; D016030:Kidney Transplantation; D014613:Vaccines, Attenuated / Q000627:therapeutic use
D014613:Vaccines, Attenuated; D000212:Acyclovir